Suchergebnisse - "antibodies"

PubPharm (1.573)

1

Infliximab Concentrations in Participants with Moderate to Severe COVID-19

enthalten in: Journal of clinical pharmacology | 2024

von Balevic, S. | Dandachi, D. | Dixon, D. | +4

2

Tocilizumab for refractory post-COVID-19 pansclerotic morphea

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Saraswat, N. | Tripathy, D. | Mishra, A. | +3

3

Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis : a cohort study

enthalten in: Annals of the rheumatic diseases | 2024

von Schiff, A. | Wang, X. | Patel, N. | +13

UpdateOf: medRxiv. 2023 Oct 09;:. - PMID 37873462

4

Sleep, work features, and SARS-cov-2 vaccine antibody response : Comment

enthalten in: Sleep medicine | 2024

von Daungsupawong, H. | Viroj, W.

5

The continuous surprises that SARS-CoV-2 presents to the scientific community - Correspondence about the Paper Fusco G, Cardillo L, Levante M, Brandi S, Picazio G, Napoletano M, Martucciello A, Fiorito F, De Carlo E, De Martinis C. First serological evidence of SARS-CoV-2 natural infection in small ruminants : brief report. Vet Res Commun. 2023 sep;47(3):1741-1748. Doi: 10.1007/s11259-022-10044-3

enthalten in: Veterinary research communications | 2024

von Teixeira, A.

6

Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination

enthalten in: The Journal of infection | 2024

von Sun, L. | Man, Q. | Zhang, H. | +5

7

COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab

enthalten in: American journal of hematology | 2024

von Fattizzo, B. | Röth, A. | Broome, C. | +4

8

Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments : A study by ERIC, the European Research Initiative on CLL

enthalten in: American journal of hematology | 2024

von Campanella, A. | Capasso, A. | Heltai, S. | +41

9

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy) : A phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: The Journal of infection | 2024

von Hites, M. | Lapique, E. | Massonnaud, C. | +84

10

Letter to the Editor Regarding "Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity"

enthalten in: Iranian journal of immunology : IJI | 2024

von Deshpande, N.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[158]